Allegra-d 12 hour and Feeling abnormal - a phase IV clinical study of FDA data
Feeling abnormal is found among people who take Allegra-d 12 hour, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Allegra-d 12 hour and have Feeling abnormal. It is created by eHealthMe based on reports of 577 people who have side effects when taking Allegra-d 12 hour from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
577 people reported to have side effects when taking Allegra-d 12 hour.
Among them, 23 people (3.99%) have Feeling abnormal.
What is Allegra-d 12 hour?
Allegra-d 12 hour has active ingredients of fexofenadine hydrochloride; pseudoephedrine hydrochloride. It is often used in allergies. eHealthMe is studying from 851 Allegra-d 12 hour users for its effectiveness, alternative drugs and more.
What is Feeling abnormal?
Feeling abnormal is found to be associated with 3,409 drugs and 3,314 conditions by eHealthMe.
Number of Allegra-d 12 hour and Feeling abnormal reports submitted per year:
Time on Allegra-d 12 hour when people have Feeling abnormal *:
Gender of people who have Feeling abnormal when taking Allegra-d 12 hour*:
Age of people who have Feeling abnormal when taking Allegra-d 12 hour *:
Common drugs people take besides Allegra-d 12 hour *:
Common side effects people have besides Feeling abnormal *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Allegra-d 12 hour and have Feeling abnormal?Check whether Feeling abnormal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Feeling abnormal and when was it recovered:
Expand to all the drugs that have ingredients of fexofenadine hydrochloride; pseudoephedrine hydrochloride:
- Feeling abnormal and drugs with ingredients of fexofenadine hydrochloride; pseudoephedrine hydrochloride
Alternative drugs to, pros and cons of Allegra-d 12 hour:
- Allegra-d 12 hour (851 reports)
Feeling abnormal treatments and more:
- Feeling abnormal (242,920 reports)
COVID vaccines that are related to Feeling abnormal:
- Feeling abnormal in Moderna COVID Vaccine
- Feeling abnormal in Pfizer BioNTech Covid Vaccine
- Feeling abnormal in Johnson and Johnson Covid Vaccine
Common drugs associated with Feeling abnormal:
- Lyrica: 10,242 reports
- Aspirin: 9,140 reports
- Humira: 7,171 reports
- Enbrel: 7,055 reports
- Synthroid: 6,389 reports
- Gabapentin: 6,296 reports
- Prednisone: 6,131 reports
- Methotrexate: 5,902 reports
- Cymbalta: 5,746 reports
- Metformin: 5,500 reports
All the drugs that are associated with Feeling abnormal:
- Feeling abnormal (3,409 drugs)
Common conditions associated with Feeling abnormal:
- Multiple sclerosis: 12,999 reports
- Depression: 12,328 reports
- Rheumatoid arthritis: 10,411 reports
- Pain: 9,586 reports
- High blood pressure: 9,400 reports
All the conditions that are associated with Feeling abnormal:
- Feeling abnormal (3,314 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fexofenadine hydrochloride; pseudoephedrine hydrochloride (the active ingredients of Allegra-d 12 hour) and Allegra-d 12 hour (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Memory Loss and drugs of ingredients of liraglutide recombinant - 15 seconds ago
- Asthma and Gallstones - 38 seconds ago
- Efudex and Xyrem drug interaction - 57 seconds ago
- Nitronal and Fatigue - a minute ago
- Ditropan and Ards (Acute Respiratory Distress Syndrome) - a minute ago
- Tinnitus and Withdrawal Syndrome - a minute ago
- Qvar vs. Advair Diskus 100/50 - 2 minutes ago
- Erythromycin and Pavulon drug interaction - 2 minutes ago
- Linzess and Canasa drug interaction - 4 minutes ago
- Acetaminophen and Taeniasis - 4 minutes ago